{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:33:41Z","timestamp":1790264021375,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.vaccine.2023.10.055","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T21:57:59Z","timestamp":1700258279000},"page":"7573-7580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda"],"prefix":"10.1016","volume":"41","author":[{"given":"Edward","family":"Man-Lik Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ggayi","family":"Abu-Baker Mustapher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Omosa-Manyonyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5771-5515","authenticated-orcid":false,"given":"Zacchaeus","family":"Anywaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Musila Mutua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ayieko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Vudriko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ann Mwangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusupha","family":"Njie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0243-5601","authenticated-orcid":false,"given":"Kakande","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Mundia Muriuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5340-7048","authenticated-orcid":false,"given":"Kambale","family":"Kasonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Edward Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nambaziira","family":"Florence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Manno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Katwere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3548-3482","authenticated-orcid":false,"given":"Chelsea","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1545-6338","authenticated-orcid":false,"given":"Auguste","family":"Gaddah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-1294","authenticated-orcid":false,"given":"Kerstin","family":"Luhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omu","family":"Anzala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontiano","family":"Kaleebu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Watson-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2023.10.055_b0005","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1099\/jgv.0.001252","article-title":"ICTV virus taxonomy profile: filoviridae","volume":"100","author":"Kuhn","year":"2019","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.055_b0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola virus disease","volume":"6","author":"Jacob","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2023.10.055_b0015","unstructured":"World Health Organization. Ebola virus disease [updated 2021 Feb 2Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ebola-virus-disease."},{"key":"10.1016\/j.vaccine.2023.10.055_b0020","doi-asserted-by":"crossref","unstructured":"Anywaine ZM, G.A. African Cities and Urban Health. Handbook of Global Urban Health: Routledge; 2019.","DOI":"10.4324\/9781315465456-26"},{"key":"10.1016\/j.vaccine.2023.10.055_b0025","unstructured":"First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response [press release]. 2019 Dec 19 2019."},{"key":"10.1016\/j.vaccine.2023.10.055_b0030","doi-asserted-by":"crossref","unstructured":"Piszczatoski CRG, Ervebo JG. (Ebola Zaire Vaccine, Live\/rVSV\u0394G-ZEBOV-GP): The First Licensed Vaccine for the Prevention of Ebola Virus Disease. Journal of Pharmacy Technology. 2020;36(6).","DOI":"10.1177\/8755122520950692"},{"key":"10.1016\/j.vaccine.2023.10.055_b0035","unstructured":"New vaccine for prevention of Ebola virus disease recommended for approval in the European Union [press release]. https:\/\/www.ema.europa.eu\/en\/news\/new-vaccine-prevention-ebola-virus-disease-recommended-approval-european-union: European Medicines Agency, 29 May 2020 2020."},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.055_b0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1473-3099(21)00125-0","article-title":"Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial","volume":"22","author":"Ishola","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2023.10.055_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003813","article-title":"Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa","volume":"18","author":"Barry","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2023.10.055_b0050","unstructured":"National Institute of Allergy and Infectious Diseases NIoH. Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events. In: Services UDoHaH, editor. Corrected Version 2.1 edJuly 2017."},{"issue":"4","key":"10.1016\/j.vaccine.2023.10.055_b0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","article-title":"B cell memory: building two walls of protection against pathogens","volume":"20","author":"Akkaya","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.055_b0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/imr.12895","article-title":"How intrinsic and extrinsic regulators of plasma cell survival might intersect for durable humoral immunity","volume":"296","author":"Robinson","year":"2020","journal-title":"Immunol Rev"},{"issue":"18","key":"10.1016\/j.vaccine.2023.10.055_b0065","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00579-19","article-title":"Dynamics of the humoral immune response to a prime-boost Ebola vaccine: quantification and sources of variation","volume":"93","author":"Pasin","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.10.055_b0070","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3389\/fimmu.2017.01380","article-title":"T follicular helper cells and B cell dysfunction in aging and HIV-1 infection","volume":"8","author":"Pallikkuth","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.055_b0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41541-022-00564-z","article-title":"Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola","volume":"7","author":"Bockstal","year":"2022","journal-title":"npj Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23012574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23012574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:32:07Z","timestamp":1759404727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23012574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":15,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0264410X23012574"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}